Citations

Mayo Clinic

Showing 10 of 108453 citations.

Microwave Ablation Versus Surgical Resection for Small (≤3 cm) Hepatocellular Carcinoma in Older Patients: A Propensity Score Matching Analysis
Chen, K H , Ji, Yimin , Wang, Gongzheng , Chen, Wen , Zhu, Qiang , Wang, Ximing , Liu, Cuihong , Zhao, Xinya , Chen, Kaige , Chen, Wen , Liu, Cuihong

Korean Journal of Radiology | June 23, 2025 | Volume: 26 | Issue: 7 | Pages: 650

10.3348/kjr.2025.0049 | PMID 40590077 Get It

P2RX7 regulates tauopathy progression via tau and mitochondria loading in extracellular vesicles
Ikezu, Tsuneya , Bodart‐Santos, Victor , You, Yang , Ellison, Justice, Radhakishun, Stephanie, Ray, Nibedita Basu, Melvin, Bridgette, Kurti, Aishe, Liang, Zhewei , Sakai, Yuta, Fiddes, Lindsey K. , Ikezu, Seiko , Ravula, Arun Reddy, Yang, You , Ruan, Zhi , Liang, Zhewei , Nguyen, Son , Shaffer, Scott , Springer, Wolfdieter , Ikezu, Tsuneya , Ravula, Arun Reddy , Abdullah, Mohammad, Ellison, Justice, Sakai, Yuta, O'Brien, Daniel, Shaffer, Scott A. , Butovsky, Oleg , Springer, Wolfdieter

No container title available | June 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6771517/v1 | PMID 40678243 Get It

Abstract P2x purinoreceptor 7 (P2RX7), an ATP-gated ion channel, is known to play pivotal roles in the progression of Alzheimer’s disease (AD), although its cell type-specific pathological mechanisms have yet to be elucidated. Here, we show that genetic deletion of P2rx7 mitigates brain atrophy, tau accumulation and cognitive impairment in PS19 tauopathy mice. Specific deletion of P2rx7 in microglia, but not astrocytes, significantly suppresses tau propagation from the entorhinal cortex to CA1 in the hippocampus, an early event in AD pathology. Single-cell (sc)-RNA sequencing of mouse brains revealed specific P2rx7 expression in microglia, inducing inflammatory changes accompanied by elevated extracellular vesicles (EVs) secretion in PS19 mice. Brain-derived EVs (BDEVs) proteome demonstrated that P2RX7 increases EV cargo loading of tau and mitochondrial molecules in BDEVs from PS19 mice, which was further validated by single-molecule super-resolution. Notably, following the injection of BDEVs isolated from PS19 mice with or without P2rx7 deficiency, the microglial transcriptome of recipient mice revealed enriched DNA-sensing and type II interferon signaling in response to BDEVs from PS19 mice, which was diminished in the group injected with P2rx7-deficient BDEVs. Thus, our results indicate that P2RX7 regulates EV-mediated tau and mitochondrial transfer and inflammatory activation in microglia with increased EV secretion, thereby contributing to tauopathy and neurodegeneration, highlighting the therapeutic potential of targeting the P2RX7-EV axis in AD.
Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study
Diaz‐Galvan, Patricia , Przybelski, Scott A. , Lesnick, Timothy G. , Nguyen, Aivi T. , Reichard, Ross R., Ono, Daisuke , Schwarz, Christopher G., Gunter, Jeffrey L. , Lowe, Val J. , Forsberg, Leah K. , Fields, Julie A. , Savica, Rodolfo , Graff‐Radford, Jonathan , Jones, David, Day, Gregory S. , Graff‐Radford, Neill, Kremers, Walter K. , Petersen, Ronald C., Jack, Clifford R. , Ferman, Tanis J. , Boeve, Bradley F., Kantarci, Kejal , Gunter, Jeffrey, Savica, Rodolfo , Graff-Radford, Jonathan , St Louis, E K , Kantarci, Kejal , Jack, Clifford R , Day, Gregory S , Ferman, Tanis J , Nguyen, Aivi T , Diaz-Galvan, Patricia , Kremers, Walter K , Murray, Melissa E. , Dickson, Dennis W. , Senjem, Matthew L. , Schwarz, Christopher G. , Ramanan, Vijay K. , Jones, David, Botha, Hugo , Louis, Erik K. St. , Knopman, David S. , Graff‐Radford, Neill, Petersen, Ronald C. , Boeve, Bradley F.

Movement Disorders | June 23, 2025 | Volume: 40 | Issue: 10 | Pages: 2129-2138

10.1002/mds.30265 | PMID 40545947 Get It

Abstract Objective To compare iron deposition in the substantia nigra (SN) as measured with quantitative susceptibility mapping (QSM) on antemortem magnetic resonance imaging (MRI) between individuals with and without Lewy‐related pathology at autopsy. Methods We performed a retrospective cohort study including 54 participants who underwent autopsy and antemortem MRI with QSM. Cases were classified as Lewy body disease (LBD)‐present (n = 13) if they had Lewy‐related pathology and LBD‐absent (n = 41) if they did not have Lewy‐related pathology. QSM was calculated for the whole SN and the two subregions: pars compacta (SNc) and pars reticulata (SNr). Nonparametric Wilcoxon rank‐sum tests were used to compare SN QSM values between LBD‐present and LBD‐absent cases. Area under the receiver operating characteristic (ROC) curve (AUC) analyses tested the accuracy of SN QSM values to distinguish the two groups. Associations of QSM values in the SN and its subregions with clinical features were tested with Spearman's correlations. Results The LBD‐present group had higher QSM values in the SNc ( P = 0.008) than the LBD‐absent group with no differences in SNr. QSM values of the SNc distinguished LBD‐present and LBD‐absent cases with good accuracy (AUC = 0.74) and correlated with the presence of parkinsonism and parkinsonism severity. Conclusions This study provides neuropathological confirmation of the utility of SNc QSM as an in vivo biomarker of Lewy‐related pathology. Imaging evidence of abnormal iron deposition in the SNc could potentially serve as a biomarker for inclusion in emerging research frameworks aimed at defining individuals with LBD based on their biological characteristics. Ultimately, this could facilitate more precise diagnoses and guide treatment strategies in LBD. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Autoimmune Inner Ear Disease from a Rheumatologic Perspective
Diaz‐Menindez, Maximiliano , Chindris, Ana‐Maria , Mead‐Harvey, Carolyn , Li, Yan , Butendieck, Ronald R., Chirilă, Răzvan M. , Britt, Katherine L., Berianu, Florentina , Chindris, Ana-Maria , Britt, Katherine L.

Diagnostics | June 23, 2025 | Volume: 15 | Issue: 13 | Pages: 1577

10.3390/diagnostics15131577 | PMID 40647576 Get It

Background/Objectives: Autoimmune inner ear disease (AIED) causes sensorineural hearing loss that classically presents as fluctuating, asymmetric loss of hearing. Associated vestibular and other ear symptoms can be present in many patients. First-line treatment of AIED is high-dose corticosteroids. AIED can present either as a primary condition limited to ear involvement or secondary, as part of an underlying systemic autoimmune rheumatic disease, the most common of which include vasculitis and relapsing polychondritis. We described our cohort of primary AIED, including demographics, treatment, and outcomes. We excluded from this review sensorineural hearing loss in the context of vasculitis and relapsing polychondritis. Methods: We performed a chart review of patients with the diagnosis of AIED at Mayo Clinic and compared the cohort by sex. Results: Thirty-one patients met the inclusion criteria. The mean age was 48.5 years, and 17 were men. Patients were initially evaluated at the Department of Otorhinolaryngology or Internal Medicine, and 29 patients were subsequently referred to the Department of Rheumatology, with a mean of 12.2 weeks after the first evaluation. Treatment with corticosteroids showed improvement in hearing and vestibular symptoms during the first month but no further improvement by the end of the third month. Other immunosuppressive medications were used with various degrees of response. Methotrexate was the second most used therapy, with 11 of 17 patients reporting an improvement in symptoms. Conclusions: Corticosteroid therapy is an effective initial treatment for AIED and should be followed with corticosteroid-sparing agents to prevent further damage to the cochlea.
Impact of Bowel Resection on Operative Mortality and Overall Survival in Advanced Epithelial Ovarian Cancer
Ceylan, O , Turan, İlyas , Erdemoğlu, Evrim , González, Marina Santos, Magrina, Javier F. , Ceylan, Özgür Ozan , Magrina, Javier, González, Marina Santos

Cancers | June 23, 2025 | Volume: 17 | Issue: 13 | Pages: 2086

10.3390/cancers17132086 | PMID 40647387 Get It

Background/Objectives: Bowel resection may be necessary during cytoreductive surgery (CS) in advanced epithelial ovarian cancer to achieve complete tumor removal. However, concerns about increased perioperative risks and unclear survival benefits have led to ongoing debate. This study aimed to evaluate the impact of bowel resection on perioperative mortality and overall survival (OS) in patients undergoing CS. Methods: We retrospectively reviewed 127 patients with FIGO stage IIB–IV epithelial ovarian cancer who underwent primary or interval CS between 2007 and 2021. Patients were stratified based on the performance of bowel resection. Clinical, surgical, and survival data were analyzed using Kaplan–Meier survival analysis and Cox proportional hazards modeling. Primary outcomes were 90-day mortality and OS. Results: Bowel resection was performed in 58 patients (46%) with more extensive disease and poorer ECOG performance scores. Although the resection group had increased perioperative risks (e.g., higher transfusion rates and ICU use), OS was similar between groups (log-rank p = 0.122). Multivariate analysis identified that increasing age (HR = 1.042, p = 0.005) was independently associated with poorer OS, whereas lymph node dissection (HR = 0.450, p = 0.003) and undergoing primary CS (HR = 0.540, p = 0.047) were associated with improved survival. Bowel resection was not independently associated with OS. Conclusions: Bowel resection does not adversely affect OS when optimal cytoreduction is achieved. Although it increases perioperative complexity, it can be safely incorporated into CS in selected patients. These findings support its use as part of an individualized surgical strategy for advanced ovarian cancer.
Placebo‐Controlled, Randomized Double‐Blind N‐Of‐1 Trial to Study Safety and Potential Efficacy of TJ‐68 for Improving Muscle Cramps in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study
Mitsumoto, Hiroshi , Oskarsson, Björn , Jang, Grace E. , Andrews, Howard , Johnson, Stephen A. , Shah, Jaimin , Fernandes, Joseph Americo, Andrews, Jinsy , Rao, Maya K., McElhiney, Martin , Oskarsson, Björn , Johnson, Stephen A , Shah, Jaimin S, Cheung, Ken , Fernandes, J. Americo

Muscle & Nerve | June 23, 2025 | Volume: 72 | Issue: 3 | Pages: 485-492

10.1002/mus.28459 | PMID 40545904 Get It

ABSTRACTIntroduction/AimsMuscle cramps are a common symptom in amyotrophic lateral sclerosis (ALS). Ameliorating muscle cramps may improve quality of life in devastating diseases like ALS. A traditional Japanese medicine (Kampo, TJ‐68) is widely prescribed in Japan for muscle cramps. However, it is not available in the USA. This study evaluated the safety, tolerability, and efficacy of TJ‐68 in ALS.MethodsThis study was a double‐blind, randomized, placebo‐controlled crossover trial, consisting of four periods, conducted at three centers in the USA. Safety was evaluated using multiple measures. The primary efficacy outcome was the Visual Analog Scale for Muscle Cramps Affecting Overall Daily Activity (item #5 of the Muscle Cramp Scale (MCS)). The secondary outcomes included the remaining items of the MCS and the Clinical Global Impression of Changes (CGIC), among others. The study was planned to enroll 22 participants with ALS within 2 years.ResultsThe enrollment was slow and was completed with 11 participants. There were no serious safety issues and TJ‐68 was well tolerated. Although the primary outcome measure did not reach statistical significance (p = 0.35), several secondary measures showed significant results: MCS #1 triggering of cramps (p = 0.01), MCS #2 cramp frequency (p = 0.03), MCS Additional 1 change of motor behaviors (p = 0.02), and CGIC assessed by the evaluator (p = 0.009). Other outcome measures did not reach statistical significance.DiscussionThe study revealed that N‐of‐1 trial design can detect changes in a small sample size, and TJ‐68 appeared to be safe. Larger studies are needed to confirm the efficacy of TJ‐68.
Knowledge and Competency of Healthcare Professionals and Medical Students in Cardiac Arrest and CPR in Pakistan: A Nationwide Cross‐Sectional Study
Kumari, Usha , Hassan, Zair , Waseem, Maria , Sahito, Moiz , Zahid, Shanzay , Patel, Kevin , Jan, Muneeb Ullah , Surani, Salim , Iqbal, Javed , Jan, Muneeb , Surani, Salim

Health Science Reports | June 23, 2025 | Volume: 8 | Issue: 6 | Pages: No page available

10.1002/hsr2.70419 | PMID 40551863 Get It

ABSTRACT Background and Aims Out‐of‐hospital cardiac arrest stands as the primary cause of worldwide mortality. Therefore, all healthcare workers must comprehensively understand and practically apply cardiopulmonary resuscitation (CPR). To address the paucity of literature on this subject, we conducted a nationwide survey among healthcare professionals in Pakistan. Methods This nationwide cross‐sectional study was based on an online questionnaire. The sample pool comprised healthcare professionals and medical students from all over Pakistan. The survey comprised 18 questions aimed to assess the comprehension of CPR, determine the source of their basic life support (BLS) training, and evaluate their competence in performing CPR in real‐life situations. Results The sample size consisted of 951 participants from Pakistan. A total of 712 responders (75%) reported having received CPR or CPR with an Automated External Defibrillator (AED) course, and the same percentage reported that their respective universities had organized the course. The responders reported that the BLS course was made mandatory in only 60% of cases. Most of the respondents were first‐year medical students (21%) and postgraduates (21%). Most of the respondents (78%) professed that the courses had been theoretical as well as practical, and 66% felt confident enacting CPR in out‐of‐hospital settings. Overall, no province was able to achieve a score of greater than 50% when assessed about their knowledge regarding cardiac arrest and CPR. Conclusion This study provides a detailed insight into Pakistan healthcare workers' CPR knowledge and perceptions belonging to different provinces, institutes, designations, and specialties. The participants reported being confident in performing CPR but demonstrated gaps when assessed regarding the revised guidelines and their performance in different scenarios. There is room for further research in overcoming the language barriers and other discrepancies faced by this study.
Surgical pathology of diffuse parenchymal lung disease in patients with polymyalgia rheumatica
Ganapaty, Suhashini , Cavazzi, Elena , Manchen, Peter , Butt, Yasmeen M. , Smith, Maxwell L. , Tazelaar, Henry D. , Roden, Anja C. , Larsen, Brandon T. , Tazelaar, Henry D. , Smith, Maxwell

Histopathology | June 23, 2025 | Volume: 87 | Issue: 3 | Pages: 453-463

10.1111/his.15483 | PMID 40545704 Get It

AimsPolymyalgia rheumatica (PMR) is a chronic autoimmune disorder that mainly affects older adults. Pulmonary disease in PMR is rare but may be under‐recognized and pathological descriptions thereof are few. We aimed to characterize diffuse parenchymal lung disease (DPLD) in PMR.Methods and resultsInstitutional archives were searched for patients having PMR and DPLD with lung tissue sampling. After excluding cases with infection, concomitant rheumatoid arthritis, or smoking‐related DPLD only, 11 patients (9 women, median age 75 years) were enrolled. Clinical history and pathology slides were reviewed. One of the 11 patients (9%) had concomitant giant cell arteritis; the remaining patients had no other rheumatological diseases. All had been treated for PMR with immunosuppression, and most presented years later (median 6 years) with non‐specific respiratory symptoms. Radiographically, bilateral ground‐glass opacities and reticulation were typical and were usually lower lobe predominant. Histologically, fibrosis was seen in 8 of 11 (73%) patients and was unclassifiable in four; non‐specific interstitial pneumonia was encountered in three patients, and usual interstitial pneumonia was seen in only one case. Evidence of acute lung injury occurred in 9 (82%) patients, including three with acute lung injury only, usually manifesting as organizing pneumonia. Diffuse alveolar haemorrhage was seen in four cases (29%), including two patients with haemoptysis and capillaritis.ConclusionsOur data corroborate prior reports of clinically significant DPLD in some patients with PMR. Histopathological findings mirror other rheumatological disorders and include diffuse alveolar haemorrhage with capillaritis. Additional studies are warranted to clarify the association between PMR and DPLD.
Personalizing Mechanical Circulatory Support for Cardiogenic Shock: A Review and Comparison of Current Devices
Fujiuchi, Bradley, Benavente, Kevin , Virk, Hafeez Ul Hassan , Alam, Mahboob , Tedford, Ryan J. , Krittanawong, Chayakrit , Tedford, Ryan J , Krittanawong, Chayakrit , Hassan Virk, Hafeez Ul , Jentzer, Jacob C. , Diepen, Sean van

Catheterization and Cardiovascular Interventions | June 23, 2025 | Volume: 106 | Issue: 2 | Pages: 1446-1458

10.1002/ccd.31698 | PMID 40545708 Get It

ABSTRACT Cardiogenic shock (CS) remains a high morbidity and mortality condition worldwide frequently complicating acute myocardial infarction (AMI) and decompensated heart failure (HF). Within the management of CS, mechanical circulatory support (MCS) devices play a critical role in maintaining hemodynamic stability, preserving end‐organ perfusion and bridging patients through to recovery, implantation of durable support or transplantation. Despite their use, optimal timing of initiation, as well as patient and device selection remain unclear. This review explores the current landscape of MCS devices, surrounding evidence and key distinctions between devices. With increasing acknowledgment for the heterogeneity of CS, understanding the strengths and limitations of each device remains crucial to improving outcomes in this high‐risk population.
Gastric Accommodation and Impact on Emptying of Solids in Gastroparesis
Yang, David Yi , Abdelnaem, Nada, Matar, Ayah , Camilleri, Michael , Matar, Ayah , Matar, Ayah

Neurogastroenterology & Motility | June 23, 2025 | Volume: 37 | Issue: 12 | Pages: No page available

10.1111/nmo.70111 | PMID 40545643 Get It

ABSTRACT Background In healthy controls, higher gastric accommodation (GA) was associated with slower gastric emptying (GE) of solids. Aims In patients with gastroparesis: (1) To investigate the association between GA and GE of solids. (2) To assess the prevalence of abnormally high GA. Methods An electronic medical records (EMR) review (2010–2024) was conducted on 745 adult patients with measured GA following 300 kcal Ensure using SPECT, and scintigraphy‐based GE of solids (320 kcal, 30% fat, egg meal). Among these patients, 284 had gastroparesis (GE < 25% emptied at 2 h or < 75% emptied at 4 h). Spearman correlation analysis examined associations between GA volume or ratio and GE at 1, 2, and 4 h, and GE T 1/2 . Results Weak positive correlations were observed between GA volume and GE of solids % at 1 and 2 h (respectively R s = 0.148, p = 0.0234, and R s = 0.121, p = 0.042). In addition, there was a correlation between GA ratio and GE of solids % at 2 h ( R s = 0.143, p = 0.0160). However, there were no significant correlations of GA with GE % at 4 h or GE T 1/2 . Among the 284 patients with gastroparesis, we had documented increased GA, assessed by postprandial minus preprandial gastric volume (> 640 mL), in 7.75%, and increased GA by GA ratio > 3.85 in 22.9%. Conclusions Among patients with gastroparesis, higher GA is associated with accelerated GE of solids in the first 2 h, though the effect size is small. There is no significant effect on delayed GE at 4 h or GE T 1/2 .